GrowingStockReport.com

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) and Staples, Inc. (NASDAQ:SPLS) Added to Growing Stock Report's NASDAQ Decliners Watch List.

 

New York, NY -- (ReleaseWire) -- 01/14/2014 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) and Staples, Inc. (NASDAQ:SPLS).

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) a biopharmaceutical company that discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally closed down in its previous session (-4.45%) on 3,067,426 shares traded after Achillion Reported HCV Pipeline Progress and Outlined 2014 HCV Milestones. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is currently down (-64.9%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

Staples, Inc. (NASDAQ:SPLS) together with its subsidiaries, operates as an office products company closed down in its previous session (-3.14%) on 8,350,222 shares traded. Staples, Inc. (NASDAQ:SPLS) is currently down (-16.76%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Staples, Inc. (NASDAQ:SPLS)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com